← Snapshot 21

Orange Book snapshot 21: Products

Products page 70 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
3452N020628001SAQUINAVIR MESYLATECAPSULE;ORALCAPSULEORALINVIRASEHOFFMANN LA ROCHEEQ 200MG BASE[]1995-12-06Dec 6, 1995NoYesNoDISCNHOFFMANN LA ROCHE INCb540af6e79e38e89ff3b6a07451be6021c9e6cab4d0f73c8baf7729ed0567d1e
3453N010929001SODIUM IODIDE I-131CAPSULE;ORALCAPSULEORALIODOTOPEBRACCO1-130mCi[]Approved Prior to Jan 1, 1982YesNoNoDISCNBRACCO DIAGNOSTICS INC71ac5bd10c3bd8f4eda6bd9b9c7ebef0280e788ff3391fd250f93ad29ffc10fc
3454N010929003SODIUM IODIDE I-131CAPSULE;ORALCAPSULEORALIODOTOPEBRACCO1-150mCi[]Approved Prior to Jan 1, 1982YesNoNoDISCNBRACCO DIAGNOSTICS INCb455204127cdc38f36e0e98080fad2b939596c5cd32ba64677387c795a8c816d
3455A205063001ISOTRETINOINCAPSULE;ORALCAPSULEORALISOTRETINOINACTAVIS LABS FL10MGAB2["AB2"]2021-03-31Mar 31, 2021NoNoNoRXACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCf802467943c6c95668944729e595f7e1a8d36503812da79bbd7dbb50cd43cbc2
3456A205063002ISOTRETINOINCAPSULE;ORALCAPSULEORALISOTRETINOINACTAVIS LABS FL20MGAB2["AB2"]2021-03-31Mar 31, 2021NoNoNoRXACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCc457f371ae0cde51c4ffe396d761e262237d13d008c3b432dc501b5d9f7b9443
3457A205063003ISOTRETINOINCAPSULE;ORALCAPSULEORALISOTRETINOINACTAVIS LABS FL25MGAB2["AB2"]2021-03-31Mar 31, 2021NoNoNoRXACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC66ef3d079bbf0ab96651366c6b7a116deb719508d8cd9d7e0891412776f4737d
3458A205063004ISOTRETINOINCAPSULE;ORALCAPSULEORALISOTRETINOINACTAVIS LABS FL30MGAB2["AB2"]2021-03-31Mar 31, 2021NoNoNoRXACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC66cb0f7fb30e73db7d08505c4ea17b03e57e815095b745b9d5473acf198de2a2
3459A205063005ISOTRETINOINCAPSULE;ORALCAPSULEORALISOTRETINOINACTAVIS LABS FL35MGAB2["AB2"]2021-03-31Mar 31, 2021NoNoNoRXACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC09b00cb480787e8453acd8a4b065cfeb694e6ce972afde8285a34bffaf1f6f9d
3460A205063006ISOTRETINOINCAPSULE;ORALCAPSULEORALISOTRETINOINACTAVIS LABS FL40MGAB2["AB2"]2021-03-31Mar 31, 2021NoNoNoRXACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC66a1c4d58a9501bac2398c584f0e2088442dab76476477cd4c0cb0f866789169
3461A207792001ISOTRETINOINCAPSULE;ORALCAPSULEORALISOTRETINOINAMNEAL PHARMS NY10MGAB1["AB1"]2017-09-29Sep 29, 2017NoNoNoRXAMNEAL PHARMACEUTICALS OF NY LLCd5a6fd886def0f8229398621ae784165af98d8d026e7e81a2ddca95325433fd7
3462A207792002ISOTRETINOINCAPSULE;ORALCAPSULEORALISOTRETINOINAMNEAL PHARMS NY20MGAB1["AB1"]2017-09-29Sep 29, 2017NoNoNoRXAMNEAL PHARMACEUTICALS OF NY LLC3a5496479844d2b2f8997280dc703ab35989abea1e3bd812931f38bfe89e4ee3
3463A207792003ISOTRETINOINCAPSULE;ORALCAPSULEORALISOTRETINOINAMNEAL PHARMS NY30MGAB1["AB1"]2017-09-29Sep 29, 2017NoNoNoRXAMNEAL PHARMACEUTICALS OF NY LLCbc914a9cb551055c2fa2cc08797ff8eeb912e475cc93059d934cda41fcb5e851
3464A207792004ISOTRETINOINCAPSULE;ORALCAPSULEORALISOTRETINOINAMNEAL PHARMS NY40MGAB1["AB1"]2017-09-29Sep 29, 2017NoNoNoRXAMNEAL PHARMACEUTICALS OF NY LLCbf4f8d25595beec9e5d54fec9ddd2b04ed52c6a2dbb1980fac30b0f17fc23722
3465A077169001ISRADIPINECAPSULE;ORALCAPSULEORALISRADIPINEELITE LABS INC2.5MGAB["AB"]2006-04-24Apr 24, 2006NoNoNoRXELITE LABORATORIES INC2e93a19da1453171f14770233d478c0c453b53101aa0027b37aa97d89076fe19
3466A077169002ISRADIPINECAPSULE;ORALCAPSULEORALISRADIPINEELITE LABS INC5MGAB["AB"]2006-04-24Apr 24, 2006NoNoNoRXELITE LABORATORIES INC3a7a25b304bd36694d6a4807c4b58e48b8576359e4311c42ce6331542f6b64b1
3467A077317001ISRADIPINECAPSULE;ORALCAPSULEORALISRADIPINEWATSON LABS TEVA2.5MGAB["AB"]2006-01-05Jan 5, 2006NoNoNoRXWATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC7847403b9b3d7a5dccdd91323fd77244c21c65252e85ee569e5d806a65c2649a
3468A077317002ISRADIPINECAPSULE;ORALCAPSULEORALISRADIPINEWATSON LABS TEVA5MGAB["AB"]2006-01-05Jan 5, 2006NoNoYesRXWATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCaeca298183a92f5f3a7c771e4400bf15cd16ce93f528b7bd59861112383b4e38
3469A205991001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLEACCORD HLTHCARE100MGAB["AB"]2016-05-26May 26, 2016NoNoNoRXACCORD HEALTHCARE INC671f467d3fe34146332f9f55a4569de77b70f6d78bb1bb38f0ab8212ff8b9d5d
3470A206741001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLEALEMBIC PHARMS LTD100MGAB["AB"]2016-12-13Dec 13, 2016NoNoNoRXALEMBIC PHARMACEUTICALS LTDae365c44945b202be6226ad53726b47a8c657266ab40f4cdf567594727f5df91
3471A208591001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLEALKEM LABS LTD100MGAB["AB"]2017-06-12Jun 12, 2017NoNoNoRXALKEM LABORATORIES LTD481aeb5e20ce0454aaec5dff2266b19179017d66b5ab6cab9f36ccd5d06994ff
3472A205080001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLEAMNEAL PHARMS100MGAB["AB"]2016-09-26Sep 26, 2016NoNoNoRXAMNEAL PHARMACEUTICALS122420e629d29bd0bcbb5eb16ab51b0b5b8e34cd61951276c9300d5c0b04cb35
3473A203445001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLEJUBILANT GENERICS100MGAB["AB"]2017-02-23Feb 23, 2017NoNoNoRXJUBILANT GENERICS LTDbe39a750ccc36ff503a1b82d5d2ec689f7c2d87740660c79ac765a696e000d64
3474A200463001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLEMYLAN PHARMS INC100MGAB["AB"]2012-07-20Jul 20, 2012NoNoNoRXMYLAN PHARMACEUTICALS INCfd4c37babd8ff1c554dca61a54b6310eaaf92029fcb120b8c9371377d56d1347
3475A205724001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLEPAR PHARM INC100MGAB["AB"]2016-12-13Dec 13, 2016NoNoNoRXPAR PHARMACEUTICAL INCab89a9491b7ba5746e890b98ef5d72a3678367baed745fb501d459504899bb46
3476A076104001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLESANDOZ100MGAB["AB"]2004-05-28May 28, 2004NoNoNoRXSANDOZ INCe21bdb7ff3ace37e506fbeadbdedb4ae5aabd0799ee8c710407d9f9b231454ad
3477A206410001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLESTRIDES PHARMA100MGAB["AB"]2019-07-02Jul 2, 2019NoNoNoRXSTRIDES PHARMA GLOBAL PTE LTD395222356f69d1f39648ca1b1fdc1e6f3e95ce9f046c7524c923506ffc6a4955
3478A209460001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLETORRENT100MGAB["AB"]2018-08-24Aug 24, 2018NoNoNoRXTORRENT PHARMACEUTICALS LTD0dc53f0dcb0b3b3606cb1d7643f2dd96bd51024af0c2d927693d76ac2468809b
3479A204672001ITRACONAZOLECAPSULE;ORALCAPSULEORALITRACONAZOLEZYDUS PHARMS100MGAB["AB"]2017-09-19Sep 19, 2017NoNoNoRXZYDUS PHARMACEUTICALS USA INCb333e2c2f45037d3171182237501abceff508284c3a81bad1f4bd8390c193d9e
3480N022460001DUTASTERIDE; TAMSULOSIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALJALYNGLAXOSMITHKLINE0.5MG;0.4MGAB["AB"]2010-06-14Jun 14, 2010NoYesYesRXGLAXOSMITHKLINE2a9dbfd6ce2cf01169014ed4224e77165cbd5617bf1446eae5e1a49e47727da1
3481N206089001TESTOSTERONE UNDECANOATECAPSULE;ORALCAPSULEORALJATENZOCLARUS158MG[]2019-03-27Mar 27, 2019NoYesNoRXCLARUS THERAPEUTICS INCfaa26f479172383fb3f586bcc2735583a7659f6534bdbf922368f815c63e9ede
3482N206089002TESTOSTERONE UNDECANOATECAPSULE;ORALCAPSULEORALJATENZOCLARUS198MG[]2019-03-27Mar 27, 2019NoYesNoRXCLARUS THERAPEUTICS INC35dd22d773eb153304aed223265c1348aec44326449cf984adfa395b1220a7c9
3483N206089003TESTOSTERONE UNDECANOATECAPSULE;ORALCAPSULEORALJATENZOCLARUS237MG[]2019-03-27Mar 27, 2019NoYesYesRXCLARUS THERAPEUTICS INC79693a74de6a9a9768751b17ddbaf712715f5e84117793b26f7a795f5942b0c4
3484N203858001LOMITAPIDE MESYLATECAPSULE;ORALCAPSULEORALJUXTAPIDAMRYTEQ 5MG BASE[]2012-12-21Dec 21, 2012NoYesNoRXAMRYT PHARMACEUTICALS DAC8158e7a6516e8d3647b1bdfb077067e4f10aaf6c786aff76f93a5f13fc366b5f
3485N203858002LOMITAPIDE MESYLATECAPSULE;ORALCAPSULEORALJUXTAPIDAMRYTEQ 10MG BASE[]2012-12-21Dec 21, 2012NoYesNoRXAMRYT PHARMACEUTICALS DACc84d6152b05386264fcb28d0f4e145d06d2ccfcb33027561b24d743455007b2a
3486N203858003LOMITAPIDE MESYLATECAPSULE;ORALCAPSULEORALJUXTAPIDAMRYTEQ 20MG BASE[]2012-12-21Dec 21, 2012NoYesNoRXAMRYT PHARMACEUTICALS DAC6501b160ca292dd602f72014835eba4c960543d53ce246874b768f5b5cd5990d
3487N203858004LOMITAPIDE MESYLATECAPSULE;ORALCAPSULEORALJUXTAPIDAMRYTEQ 30MG BASE[]2015-04-23Apr 23, 2015NoYesNoRXAMRYT PHARMACEUTICALS DAC4322322cf8840bd97d33afff86cdbf1fb9d3023707cb7b33524f2e77407069cd
3488N203858005LOMITAPIDE MESYLATECAPSULE;ORALCAPSULEORALJUXTAPIDAMRYTEQ 40MG BASE[]2015-04-23Apr 23, 2015NoYesNoDISCNAMRYT PHARMACEUTICALS DACf95d9617ac13fbdfb4da92f9416d273baac0ad3adad51bc1cad2d99c856b351f
3489N203858006LOMITAPIDE MESYLATECAPSULE;ORALCAPSULEORALJUXTAPIDAMRYTEQ 60MG BASE[]2015-04-23Apr 23, 2015NoYesNoDISCNAMRYT PHARMACEUTICALS DAC7147e82900376920b6811c4c20030cea91a4460833e2469257c9dbdbf63e8f90
3490N050219001CEPHALOGLYCINCAPSULE;ORALCAPSULEORALKAFOCINLILLY250MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNELI LILLY AND COd830aae13849dd597802c2609c57f3cdf9ef29c2660e3b5f599bc010e605eb12
3491N021226001LOPINAVIR; RITONAVIRCAPSULE;ORALCAPSULEORALKALETRAABBVIE133.3MG;33.3MG[]2000-09-15Sep 15, 2000NoNoNoDISCNABBVIE INC0a1412433532ec453a3d332eefea9a56bbfe388abc12eeef9c0e895f6e8557dd
3492A060516001KANAMYCIN SULFATECAPSULE;ORALCAPSULEORALKANTREXAPOTHECONEQ 500MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNAPOTHECON INC DIV BRISTOL MYERS SQUIBB69b2e7cf86d169c3d4b8f695d13bb4cb3825b85abb036215b7e39f960a2b6820
3493A061911001KANAMYCIN SULFATECAPSULE;ORALCAPSULEORALKANTREXAPOTHECONEQ 500MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNAPOTHECON INC DIV BRISTOL MYERS SQUIBB1f93b43abcebc37fb55c5378ffdcf817ac770bd5af6d6a6312eb18c2ca8b5de3
3494A062726001KANAMYCIN SULFATECAPSULE;ORALCAPSULEORALKANTREXAPOTHECONEQ 500MG BASE[]1987-03-06Mar 6, 1987NoNoNoDISCNAPOTHECON INC DIV BRISTOL MYERS SQUIBB9153e93635570328914802b638bec0568c659394a2807bd96fc6e9f383d7ed78
3495N050405002CEPHALEXINCAPSULE;ORALCAPSULEORALKEFLEXPRAGMAEQ 250MG BASEAB["AB"]Approved Prior to Jan 1, 1982YesYesNoRXPRAGMA PHARMACEUTICALS LLC0b5d9bbac8053b479f9d1fe4e4b91041083c01a40086f08b5e5831b5c2154b09
3496N050405004CEPHALEXINCAPSULE;ORALCAPSULEORALKEFLEXPRAGMAEQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]2006-05-12May 12, 2006NoYesNoDISCNPRAGMA PHARMACEUTICALS LLC417dea85f9581f366f2a06cebd7e654fbf5009685a427c9798c0e1a0f3478a41
3497N050405003CEPHALEXINCAPSULE;ORALCAPSULEORALKEFLEXPRAGMAEQ 500MG BASEAB["AB"]Approved Prior to Jan 1, 1982YesYesNoRXPRAGMA PHARMACEUTICALS LLCbb1447f127f280bf84f4067f54fd6b88720837bbad8461150fc1faffb78d936b
3498N050405005CEPHALEXINCAPSULE;ORALCAPSULEORALKEFLEXPRAGMAEQ 750MG BASEAB["AB"]2006-05-12May 12, 2006NoYesYesRXPRAGMA PHARMACEUTICALS LLCddee5225520c6f5d1a1421bf5d12cd68998993b8ae0be2c300bca2d0eb371083
3499A083544001PROPOXYPHENE HYDROCHLORIDECAPSULE;ORALCAPSULEORALKESSO-GESICMK LABS65MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNMK LABORATORIES INCcb5dfa9a33150cfb75442847223346109e5318a15f6dd7f5df277db5542e0db0
3500A074014001KETOPROFENCAPSULE;ORALCAPSULEORALKETOPROFENHERITAGE PHARMS INC25MG[]1993-01-29Jan 29, 1993NoNoNoRXHERITAGE PHARMACEUTICALS INC10b4fe974983d2b621504e81a90029a24e40515ad633230e983498ae284bb6cc
3501A074014002KETOPROFENCAPSULE;ORALCAPSULEORALKETOPROFENHERITAGE PHARMS INC50MGAB["AB"]1993-01-29Jan 29, 1993NoNoNoRXHERITAGE PHARMACEUTICALS INC7386b2287dbe595ac99e212457501c3b7fd3cf63cd3cb1af000a2874ebd12795